Association between cardiometabolic index and controlled attenuation parameter in U.S. adults with NAFLD: findings from NHANES (2017–2020)

Wen-feng Xi,Ai-ming Yang

DOI: https://doi.org/10.1186/s12944-024-02027-x

2024-02-10

Lipids in Health and Disease

Abstract:Cardiometabolic index (CMI), a novel indicator that combines abdominal obesity and lipid levels, has been confirmed to correlate with non-alcoholic fatty liver disease (NAFLD). However, limited research has been conducted on the relationship between CMI and controlled attenuation parameter (CAP), a parameter measured by transient elastography and reflecting the extent of fat accumulation in the liver. The objective of our study was to investigate the relationship between the two variables.

biochemistry & molecular biology,nutrition & dietetics

What problem does this paper attempt to address?

The paper attempts to address the relationship between the Cardio-Metabolic Index (CMI) and the Controlled Attenuation Parameter (CAP). Specifically, the researchers aim to understand whether CMI can serve as an ideal indicator for monitoring the degree of hepatic steatosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).

### Background
- **Non-Alcoholic Fatty Liver Disease (NAFLD)**: It is one of the leading causes of chronic liver disease, with a global prevalence of approximately 25%. With the increasing prevalence of obesity and metabolic syndrome, the incidence of NAFLD is also rising. NAFLD may progress to Non-Alcoholic Steatohepatitis (NASH) and even Hepatocellular Carcinoma (HCC).
- **Transient Elastography (TE)**: It is a non-invasive ultrasound technique used to assess the degree of liver fibrosis and steatosis. TE includes two main parameters: Liver Stiffness Measurement (LSM) and Controlled Attenuation Parameter (CAP). CAP is used to assess liver fat content.
- **Cardio-Metabolic Index (CMI)**: Proposed by Japanese scholar Wakabayashi in 2015, it estimates visceral adipose tissue by combining the ratio of triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C) and the waist-to-height ratio (WHtR). Previous studies have shown that CMI is associated with various metabolic-related diseases, such as type 2 diabetes and stroke.

### Research Objectives
- **Primary Objective**: To explore the relationship between CMI and CAP to evaluate whether CMI can serve as a convenient and cost-effective indicator for monitoring the degree of hepatic steatosis in NAFLD patients.

### Methods
- **Study Design**: This is a cross-sectional study with data from the National Health and Nutrition Examination Survey (NHANES) from 2017 to 2020, including a total of 1,759 adult NAFLD patients.
- **Variable Definitions**:
- **CMI**: Calculated as [waist circumference (cm) / height (cm)] × [TG (mmol/L) / HDL-C (mmol/L)].
- **CAP**: Measured by transient elastography, reflecting the degree of liver fat accumulation.
- **Statistical Analysis**: Multivariable linear regression, generalized additive models, and subgroup analyses were used to explore the relationship between CMI and CAP.

### Results
- **Main Findings**: There is a positive correlation between CMI and CAP. The multivariable linear regression model showed that for every 1-unit increase in CMI, CAP increased by 10.40 dB/m (95% CI, 7.14–13.67). Trend tests indicated a linear relationship between the two. Generalized additive models and segmented regression also supported this linear relationship.
- **Subgroup Analysis**: The positive correlation between CMI and CAP remained significant in most subgroups.

### Conclusion
- **Main Conclusion**: CMI is positively correlated with CAP in adult NAFLD patients, suggesting that CMI may be an ideal indicator for monitoring the degree of hepatic steatosis in NAFLD patients.

### Discussion
- **Research Significance**: This study extends previous research on the relationship between CMI and NAFLD, further confirming the potential application value of CMI in monitoring the severity of NAFLD.
- **Limitations**: Due to the cross-sectional study design, causality cannot be established; the study population is limited to American adults, which may limit the generalizability of the results; despite adjusting for some covariates, there may still be unadjusted confounding factors; the diagnosis of hepatic steatosis relies on transient elastography rather than liver biopsy.

### Outlook
Larger-scale prospective studies are needed in the future to validate these findings.